Pharming Group N.V. (AMS:PHARM)
Netherlands
· Delayed Price · Currency is EUR 1.361
+0.031 (2.33%)
At close: Mar 9, 2026
Pharming Group Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 932 | 627 | 690 | 707 | 503 | 812 | Upgrade
|
| Market Cap Growth | 53.66% | -9.08% | -2.41% | 40.66% | -38.05% | -17.99% | Upgrade
|
| Enterprise Value | 902 | 587 | 658 | 657 | 487 | 787 | Upgrade
|
| Last Close Price | 1.36 | 0.93 | 1.03 | 1.08 | 0.78 | 1.27 | Upgrade
|
| PE Ratio | 2864.08 | - | - | 55.27 | 35.75 | 26.30 | Upgrade
|
| Forward PE | 63.30 | - | 163.65 | 27.10 | 16.92 | 15.76 | Upgrade
|
| PS Ratio | 3.02 | 2.19 | 3.11 | 3.68 | 2.88 | 4.68 | Upgrade
|
| PB Ratio | 4.13 | 2.94 | 3.49 | 3.69 | 2.96 | 5.41 | Upgrade
|
| P/TBV Ratio | 8.43 | 4.06 | 5.17 | 5.82 | 5.23 | 10.47 | Upgrade
|
| P/FCF Ratio | 20.75 | - | - | 35.85 | 21.10 | 12.57 | Upgrade
|
| P/OCF Ratio | 20.51 | - | - | 33.66 | 15.11 | 11.87 | Upgrade
|
| EV/Sales Ratio | 2.92 | 2.05 | 2.97 | 3.41 | 2.78 | 4.54 | Upgrade
|
| EV/EBITDA Ratio | 20.96 | 188.69 | - | 40.97 | 18.22 | 11.66 | Upgrade
|
| EV/EBIT Ratio | 26.02 | - | - | 67.70 | 23.07 | 12.62 | Upgrade
|
| EV/FCF Ratio | 20.08 | - | - | 33.29 | 20.43 | 12.19 | Upgrade
|
| Debt / Equity Ratio | 0.50 | 0.51 | 0.78 | 0.82 | 0.84 | 0.88 | Upgrade
|
| Debt / EBITDA Ratio | 2.55 | 17.02 | - | 8.46 | 4.88 | 1.92 | Upgrade
|
| Debt / FCF Ratio | 2.48 | - | - | 7.91 | 5.97 | 2.05 | Upgrade
|
| Net Debt / Equity Ratio | -0.13 | -0.25 | -0.19 | -0.20 | -0.16 | -0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.74 | -17.24 | 2.74 | -2.37 | -0.99 | -0.52 | Upgrade
|
| Net Debt / FCF Ratio | -0.67 | 21.50 | 2.24 | -1.93 | -1.11 | -0.55 | Upgrade
|
| Asset Turnover | 0.81 | 0.69 | 0.55 | 0.50 | 0.49 | 0.63 | Upgrade
|
| Inventory Turnover | 0.57 | 0.63 | 0.51 | 0.50 | 0.87 | 1.26 | Upgrade
|
| Quick Ratio | 2.39 | 2.96 | 3.28 | 3.90 | 4.69 | 3.09 | Upgrade
|
| Current Ratio | 3.16 | 3.77 | 4.06 | 4.65 | 5.33 | 3.43 | Upgrade
|
| Return on Equity (ROE) | 0.03% | -5.38% | -4.98% | 6.88% | 8.50% | 25.09% | Upgrade
|
| Return on Assets (ROA) | 5.76% | -0.52% | -3.06% | 1.57% | 3.68% | 14.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.08% | -2.10% | -12.76% | 5.79% | 10.98% | 54.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.70% | -1.10% | -5.70% | 2.80% | 6.80% | 22.30% | Upgrade
|
| Earnings Yield | 0.03% | -1.82% | -1.38% | 1.81% | 2.80% | 3.80% | Upgrade
|
| FCF Yield | 4.82% | -0.40% | -2.46% | 2.79% | 4.74% | 7.95% | Upgrade
|
| Buyback Yield / Dilution | 2.65% | -2.18% | 7.09% | -0.85% | -2.70% | -1.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.